August 08, 2022

On August 5, 2022, the U.S. Food and Drug Administration (FDA) approved fam-trastuzumab deruxtecan-nxki (Enhertu®) for use in adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH‑) breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.

August 02, 2022

Research and practice changes funded through healthcare legislation have influenced today’s care delivery across all settings: hospitals, clinics, and even homes. And with their constituents laser-focused on health in today’s pandemic society, legislators have never made that happen so quickly.

August 01, 2022

ONS reaps value and benefits from its many collaborations and teamwork—whether between members and staff the Society’s own partnerships with and memberships in other organizations. You may see the outcomes that ONS achieves from those organizational relationships, but you may not yet realize the direct benefit they have for you as well.

July 28, 2022

Summer is synonymous with vacations, and vacations require logistical preparation. (What will I pack? What should I plan to do?) But it’s also important to ready yourself mentally for a period of wellness and rejuvenation to reap the full benefits of a well-deserved getaway. Making a checklist can help eliminate the stress of both, before and during your travel.